Parasitic infections in travelers and immigrants: part II helminths and ectoparasites

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 UNTWO. Tourism Highlights (2012 Edition). World Tourism Organization. http://dtxtq4w60xqpw.cloudfront.net/sites/all/files/pdf/unwto_highlights13_en_hr_0.pdf.
  Google Scholar
• 2 World Migration Report 2013 http://publications.iom.int/bookstore/free/WMR2013_EN.pdf.
  Google Scholar
• 3 Utzinger J, Becker SL, Knopp S et al. Neglected tropical diseases: diagnosis, clinical management, treatment and control. Swiss Med. Wkly 142, w13727 (2012).
  MedlineGoogle Scholar
• 4 Monge-Maillo B, Jimenez BC, Perez-Molina JA et al. Imported infectious diseases in mobile populations, Spain. Emerg. Infect. Dis. 15, 1745–1752 (2009).
  MedlineGoogle Scholar
• 5 Norman FF, Perez de Ayala A, Perez-Molina JA, Monge-Maillo B, Zamarron P, Lopez-Velez R. Neglected tropical diseases outside the tropics. PLoS Negl. Trop. Dis. 4, e762 (2010).
  MedlineGoogle Scholar
• 6 Zamarron Fuertes P, Perez-Ayala A, Perez Molina JA et al. Clinical and epidemiological characteristics of imported infectious diseases in Spanish travelers. J. Travel Med. 17, 303–309 (2010).
  MedlineGoogle Scholar
• 7 Harvey K, Esposito DH, Han P et al. Centers for Disease Control and Prevention (CDC): Surveillance for travel-related disease ‐‐ GeoSentinel Surveillance System, United States, 1997–2011. MMWR Surveill. Summ. 62, 1–23 (2013).
  MedlineGoogle Scholar
• 8 Monge-Maillo B, Norman FF, Perez-Molina JA, Navarro M, Diaz-Menendez M, Lopez-Velez R. Travelers visiting friends and relatives (VFR) and imported infectious disease: travelers, immigrants or both? A comparative analysis. Travel Med. Infect. Dis. 12, 88–94 (2014).
  Medline CASGoogle Scholar
• 9 Leder K, Tong S, Weld L et al. GeoSentinel Surveillance Network: illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin. Infect. Dis. 43, 1185–1193 (2006).
  MedlineGoogle Scholar
• 10 Norman FF, Monge-Maillo B, Martínez-Pérez A, Perez-Molina JA, López-Vélez R. Parasitic infections in travelers and immigrants: part I Protozoa. Future Microbiol. 10(1), 69–86 (2014).
  Google Scholar
• 11 WHO. Deworming for health and development. Report of the third global meeting of the partners for parasite control. http://whqlibdoc.who.int/hq/2005/who_cds_cpe_pvc_2005.14.pdf.
  Google Scholar
• 12 Boggild AK, Yohanna S, Keystone JS, Kain KC. Prospective analysis of parasitic infections in Canadian travelers and immigrants. J. Travel Med. 13, 138–144 (2006).
  MedlineGoogle Scholar
• 13 McCarthy AE, Weld LH, Barnett ED et al. GeoSentinel Surveillance Network: Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997–2009, part 2: migrants resettled internationally and evaluated for specific health concerns. Clin. Infect. Dis. 56, 925–933 (2013).
  MedlineGoogle Scholar
• 14 ten Hove RJ, van Esbroeck M, Vervoort T, van den Ende J, van Lieshout L, Verweij JJ. Molecular diagnostics of intestinal parasites in returning travellers. Eur. J. Clin. Microbiol. Infect. Dis. 28, 1045–1053 (2009).
  Medline CASGoogle Scholar
• 15 Schar F, Trostdorf U, Giardina F et al. Strongyloides stercoralis: Global Distribution and Risk Factors. PLoS Negl. Trop. Dis. 7, e2288 (2013).
  MedlineGoogle Scholar
• 16 Verweij JJ, Canales M, Polman K et al. Molecular diagnosis of Strongyloides stercoralis in faecal samples using real-time PCR. Trans R Soc Trop Med Hyg. 103, 342–346 (2009).
  Medline CASGoogle Scholar
• 17 Treatment Guidelines. Drugs for Parasitic Infections. The Medical Letter, Inc., Rochelle, New York (2013). http://gorgas.dom.uab.edu/syllabus/2014/03_Parasites/RxParasitesMedicalLetter2013.pdf.•• Recommendations for the treatment of the main parasitic diseases
  Google Scholar
• 18 Adegnika AA, Zinsou JF, Issifou S et al. Efficacy of single versus repeated dose albendazole to treat Ascaris lumbricoides, Trichuris trichiura and hookworm infection: A randomized controlled assessor-blinded clinical trial. Antimicrob. Agents Chemother. 58, 2535–40 (2014).
  MedlineGoogle Scholar
• 19 Lipner EM, Law MA, Barnett E et al. GeoSentinel Surveillance Network: Filariasis in travelers presenting to the GeoSentinel Surveillance Network. PLoS Negl. Trop. Dis. 1, e88 (2007).
  MedlineGoogle Scholar
• 20 Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet 376, 1175–1185 (2010).
  MedlineGoogle Scholar
• 21 Debrah AY, Mand S, Marfo-Debrekyei Y et al. Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline. Am. J. Trop. Med. Hyg. 80, 956–963 (2009).
  Medline CASGoogle Scholar
• 22 Genchi C, Kramer LH, Sassera D, Bandi C. Wolbachia and its implications for the immunopathology of filariasis. Endocr. Metab. Immune Disord. Drug Targets. 12, 53–56 (2012).
  Medline CASGoogle Scholar
• 23 Hoerauf A, Pfarr K, Mand S, Debrah AY, Specht S. Filariasis in Africa ‐‐ treatment challenges and prospects. Clin Microbiol Infect. 17, 977–985 (2011).
  Medline CASGoogle Scholar
• 24 Burbelo PD, Leahy HP, Iadarola MJ, Nutman TB. A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl. Trop. Dis. 3, e438 (2009).
  MedlineGoogle Scholar
• 25 Geary TG, Mackenzie CD. Progress and challenges in the discovery of macrofilaricidal drugs. Expert Rev. Anti Infect. Ther. 9, 681–695 (2011).
  MedlineGoogle Scholar
• 26 Antinori S, Schifanella L, Million M et al. Imported Loa loa filariasis: three cases and a review of cases reported in non-endemic countries in the past 25 years. Int. J. Infect. Dis. 16, e649–e662 (2012).
  MedlineGoogle Scholar
• 27 Diaz-Menendez M, Norman F, Monge-Maillo B, Perez-Molina JA, Lopez-Velez R. Filariasis in clinical practice. Enferm. Infecc. Microbiol Clin. 29, 27–37 (2011).
  MedlineGoogle Scholar
• 28 Jimenez M, Gonzalez LM, Carranza C et al. Detection and discrimination of Loa loa, Mansonella perstans and Wuchereria bancrofti by PCR-RFLP and nested-PCR of ribosomal DNA ITS1 region. Exp. Parasitol. 127, 282–286 (2011).
  Medline CASGoogle Scholar
• 29 Budke CM, Carabin H, Ndimubanzi PC et al. A systematic review of the literature on cystic echinococcosis frequency worldwide and its associated clinical manifestations. Am. J. Trop. Med. Hyg. 88, 1011–1027 (2013).
  MedlineGoogle Scholar
• 30 Diaz-Menendez M, Perez-Molina JA, Norman FF et al. Management and outcome of cardiac and endovascular cystic echinococcosis. PLoS Negl. Trop. Dis. 6, e1437 (2012).
  MedlineGoogle Scholar
• 31 WHO Informal Working Group on Echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bull. World Health Organ. 74, 231–242 (1996).
  MedlineGoogle Scholar
• 32 Ito A, Nakao M, Wandra T. Human Taeniasis and cysticercosis in Asia. Lancet 362, 1918–1920 (2003).
  MedlineGoogle Scholar
• 33 Zammarchi L, Strohmeyer M, Bartalesi F et al. for COHEMI Project Study Group. Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990–2011. PLoS ONE 8, e69537 (2013).• Comprehensive review of Taenia solium infection in Europe
  Medline CASGoogle Scholar
• 34 Bruno E, Bartoloni A, Zammarchi L et al. for COHEMI Project Study Group. Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis. PLoS Negl. Trop. Dis. 7, e2480 (2013).
  MedlineGoogle Scholar
• 35 Gabriel S, Blocher J, Dorny P et al. Added value of antigen ELISA in the diagnosis of neurocysticercosis in resource poor settings. PLoS Negl. Trop. Dis. 6, e1851 (2012).
  MedlineGoogle Scholar
• 36 Leder K, Torresi J, Libman MD et al. for GeoSentinel Surveillance Network. GeoSentinel surveillance of illness in returned travelers, 2007–2011. Ann. Intern. Med. 158, 456–468 (2013).
  MedlineGoogle Scholar
• 37 Clerinx J, Van Gompel A. Schistosomiasis in travellers and migrants. Travel Med. Infect. Dis. 9, 6–24 (2011).
  MedlineGoogle Scholar
• 38 Leshem E, Meltzer E, Marva E, Schwartz E. Travel-related schistosomiasis acquired in Laos. Emerg. Infect. Dis. 15, 1823–1826 (2009).
  MedlineGoogle Scholar
• 39 Mbabazi PS, Andan O, Fitzgerald DW, Chitsulo L, Engels D, Downs JA. Examining the relationship between urogenital schistosomiasis and HIV infection. PLoS Negl. Trop. Dis. 5, e1396 (2011).
  MedlineGoogle Scholar
• 40 Cnops L, Soentjens P, Clerinx J, Van Esbroeck M. A Schistosoma haematobium-specific real-time PCR for diagnosis of urogenital schistosomiasis in serum samples of international travelers and migrants. PLoS Negl. Trop. Dis. 7, e2413 (2013).
  MedlineGoogle Scholar
• 41 Van Gool T, Vetter H, Vervoort T, Doenhoff MJ, Wetsteyn J, Overbosch D. Serodiagnosis of imported schistosomiasis by a combination of a commercial indirect hemagglutination test with Schistosoma mansoni adult worm antigens and an enzyme-linked immunosorbent assay with S. mansoni egg antigens. J. Clin. Microbiol. 40, 3432–3437 (2002).
  MedlineGoogle Scholar
• 42 Logan S, Armstrong M, Moore E et al. Acute schistosomiasis in travelers: 14 years’ experience at the Hospital for Tropical Diseases, London. Am. J. Trop. Med. Hyg. 88, 1032–1034 (2013).
  MedlineGoogle Scholar
• 43 Olliaro PL, Vaillant MT, Belizario VJ et al. A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil. PLoS Negl. Trop. Dis. 5, e1165 (2011).
  Medline CASGoogle Scholar
• 44 Gryseels B, Mbaye A, De Vlas SJ et al. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop. Med. Int. Health 6, 864–873 (2001).
  Medline CASGoogle Scholar
• 45 Helleberg M, Thybo S. High rate of failure in treatment of imported schistosomiasis. J. Travel Med. 17, 94–99 (2010).
  MedlineGoogle Scholar
• 46 Li HJ, Wang W, Qu GL et al. Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice. Parasitol. Res. 110, 1727–1732 (2012).
  MedlineGoogle Scholar
• 47 Perez del Villar L, Burguillo FJ, Lopez-Aban J, Muro A. Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis. PLoS ONE 7, e45867 (2012).
  MedlineGoogle Scholar
• 48 Furst T, Duthaler U, Sripa B, Utzinger J, Keiser J. Trematode infections: liver and lung flukes. Infect. Dis. Clin. North Am. 26, 399–419 (2012).
  MedlineGoogle Scholar
• 49 Lopez-Velez R, Dominguez-Castellano A, Garron C. Successful treatment of human fascioliasis with triclabendazole. Eur. J. Clin. Microbiol. Infect. Dis. 18, 525–526 (1999).
  Medline CASGoogle Scholar
• 50 Jensenius M, Flaegstad T, Stenstad T et al. Fascioliasis imported to Norway. Scand. J. Infect. Dis. 37, 534–537 (2005).
  MedlineGoogle Scholar
• 51 Intapan PM, Khotsri P, Kanpittaya J, Chotmongkol V, Sawanyawisuth K, Maleewong W. Immunoblot diagnostic test for neurognathostomiasis. Am. J. Trop. Med. Hyg. 83, 927–929 (2010).
  MedlineGoogle Scholar
• 52 Janwan P, Intapan PM, Yamasaki H et al. Application of recombinant Gnathostoma spinigerum matrix metalloproteinase-like protein for serodiagnosis of human gnathostomiasis by immunoblotting. Am. J. Trop. Med. Hyg 89, 63–67 (2013).
  Medline CASGoogle Scholar
• 53 Gottstein B, Pozio E, Nockler K. Epidemiology, diagnosis, treatment, and control of trichinellosis. Clin. Microbiol. Rev. 22, 127–145 (2009).• Comprehensive review of Trichinella sp. infections.
  Medline CASGoogle Scholar
• 54 Turrientes MC, Perez de Ayala A, Norman F et al. Visceral larva migrans in immigrants from latin america. Emerg. Infect. Dis. 17, 1263–1265 (2011).
  MedlineGoogle Scholar
• 55 Lederman ER, Weld LH, Elyazar IR et al. for GeoSentinel Surveillance Network. Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network. Int. J. Infect. Dis. 12, 593–602 (2008).• Informative article on cutaneous illness in returning travelers.
  MedlineGoogle Scholar
• 56 Ansart S, Perez L, Jaureguiberry S, Danis M, Bricaire F, Caumes E. Spectrum of dermatoses in 165 travelers returning from the tropics with skin diseases. Am. J. Trop. Med. Hyg. 76, 184–186 (2007).
  MedlineGoogle Scholar
• 57 Hannam P, Khairnar K, Downey J, Powis J, Ralevski F, Pillai DR. Cutaneous myiasis in traveler returning from Ethiopia. Emerg. Infect. Dis. 17, 2385–2386 (2011).
  MedlineGoogle Scholar
• 58 Puente S, Otranto D, Panadero R et al. First diagnosis of an imported human myiasis caused by Hypoderma sinense (Diptera: Oestridae), detected in a European traveler returning from India. J. Travel Med. 17, 419–423 (2010).
  MedlineGoogle Scholar
• 59 Davis RF, Johnston GA, Sladden MJ. Recognition and management of common ectoparasitic diseases in travelers. Am. J. Clin. Dermatol. 10, 1–8 (2009).
  MedlineGoogle Scholar
• 60 Shimose L, Munoz-Price LS. Diagnosis, prevention, and treatment of scabies. Curr. Infect. Dis. Rep. 15, 426–431 (2013).
  MedlineGoogle Scholar
• 61 Goldust M, Rezaee E, Raghifar R, Hemayat S. Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream. Ann. Parasitol. 59, 79–84 (2013).
  MedlineGoogle Scholar